These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12708602)

  • 1. Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin.
    Burian M; Freudenstein J; Tegtmeier M; Naser-Hijazi B; Henneicke-von Zepelin HH; Legrum W
    Int J Clin Pharmacol Ther; 2003 Apr; 41(4):141-7. PubMed ID: 12708602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
    Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
    Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.
    Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T
    Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.
    Schmeck-Lindenau HJ; Naser-Hijazi B; Becker EW; Henneicke-von Zepelin HH; Schnitker J
    Int J Clin Pharmacol Ther; 2003 May; 41(5):193-9. PubMed ID: 12776809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
    Nakajima M
    Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
    Oscarson M; McLellan RA; Asp V; Ledesma M; Bernal Ruiz ML; Sinues B; Rautio A; Ingelman-Sundberg M
    Hum Mutat; 2002 Oct; 20(4):275-83. PubMed ID: 12325023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians.
    Inoue K; Yamazaki H; Shimada T
    Arch Toxicol; 2000 Jan; 73(10-11):532-9. PubMed ID: 10663384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study.
    Vanscheidt W; Rabe E; Naser-Hijazi B; Ramelet AA; Partsch H; Diehm C; Schultz-Ehrenburg U; Spengel F; Wirsching M; Götz V; Schnitker J; Henneicke-von Zepelin HH
    Vasa; 2002 Aug; 31(3):185-90. PubMed ID: 12236023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
    Fukami T; Nakajima M; Higashi E; Yamanaka H; Sakai H; McLeod HL; Yokoi T
    Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Researches on the polymorphism of cytochrome P450 2A6].
    Tong Z; ZhuGe J; Yu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):424-7. PubMed ID: 12362322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2A6: genetics, structure, regulation, and function.
    Raunio H; Rahnasto-Rilla M
    Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.
    Mahavorasirikul W; Tassaneeyakul W; Satarug S; Reungweerayut R; Na-Bangchang C; Na-Bangchang K
    Eur J Clin Pharmacol; 2009 Apr; 65(4):377-84. PubMed ID: 19082995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
    Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
    Gambier N; Batt AM; Marie B; Pfister M; Siest G; Visvikis-Siest S
    Pharmacogenomics J; 2005; 5(4):271-5. PubMed ID: 15940289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
    Ho MK; Mwenifumbo JC; Zhao B; Gillam EM; Tyndale RF
    Pharmacogenet Genomics; 2008 Jan; 18(1):67-75. PubMed ID: 18216723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2A6: a human coumarin 7-hydroxylase.
    Pelkonen O; Rautio A; Raunio H; Pasanen M
    Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
    Hadidi H; Zahlsen K; Idle JR; Cholerton S
    Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
    Paschke T; Riefler M; Schuler-Metz A; Wolz L; Scherer G; McBride CM; Bepler G
    Toxicology; 2001 Nov; 168(3):259-68. PubMed ID: 11684323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.